Novo Nordisk Cash on Hand 2010-2025 | NVO

Novo Nordisk cash on hand for the quarter ending March 31, 2025 was $6.374B, a 295.45% increase year-over-year.

  • Novo Nordisk cash on hand for 2024 was $4.732B, a 0.05% increase from 2023.
  • Novo Nordisk cash on hand for 2023 was $4.73B, a 27% increase from 2022.
  • Novo Nordisk cash on hand for 2022 was $3.724B, a 22.08% increase from 2021.

Novo Nordisk Cash on Hand 2010-2025 | NVO

  • Novo Nordisk cash on hand for 2024 was $4.732B, a 0.05% increase from 2023.
  • Novo Nordisk cash on hand for 2023 was $4.73B, a 27% increase from 2022.
  • Novo Nordisk cash on hand for 2022 was $3.724B, a 22.08% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$796.4B
Johnson & Johnson (JNJ)$379.5B
AbbVie (ABBV)$306B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Merck (MRK)$196.7B
Sanofi (SNY)$128.6B
Pfizer (PFE)$125.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B